5JD0.F ExpreS2ion Biotech Holding AB (publ)

Healthcare Biotechnology Frankfurt Exchange
0.0554 EUR
Close of Nov 11, 2026
0.0280 1.73
Market cap
EUR 2.19M
P/E
-
P/B
0.55x
ROE
-92.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 5JD0.F undervalued?

Graham number

The Graham number of ExpreS2ion Biotech Holding AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ExpreS2ion Biotech Holding AB (publ) fundamental analysis

No fundamental analysis for ExpreS2ion Biotech Holding AB (publ) yet.

ExpreS2ion Biotech Holding AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ExpreS2ion Biotech Holding AB (publ)

ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company's lead asset is ES2B-C001, an immunotherapy candidate, which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2, as well as vaccines for Nipah virus, Malaria, and influenza. It also offers GlycoX-S2, a glyco-e…

Full company profile